+987.9%
MRNA vs GPC
+6.5%
+981.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GPC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +1.7% | +11.4% | +12.2% |
| 7D | +20.6% | +4.1% | +16.5% | +18.2% |
| 30D | +27.1% | +0.1% | +27.0% | +25.6% |
| 3M | +353.4% | -3.9% | +357.3% | +364.4% |
| 6M | +446.3% | +24.4% | +421.9% | +416.0% |
| YTD | +776.2% | +5.7% | +770.5% | +633.5% |
| 1Y | +987.9% | +6.8% | +981.2% | +770.2% |
| All | +987.9% | +6.5% | +981.5% | +770.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GPC.
Daily Out/Under-Performance
Portfolio return minus GPC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GPC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GPC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling